Rigshospitalet, University of Copenhagen
Glostrup, Denmark
Mikkel Østergaard
University of Copenhagen and the National Hospital (Rigshospitalet), Denmark
Mikkel Østergaard is Professor of Rheumatology at University of Copenhagen and the National Hospital (Rigshospitalet), Denmark. He obtained his medical degree from the University of Copenhagen in 1990 and went on to become a research fellow at The Danish Research Center of Magnetic Resonance and Department of Rheumatology, obtaining his PhD in 1996, and doctoral degree (DMSc) in 1999. He is the chair of the Copenhagen Center for Arthritis Research (COPECARE).
His PhD and doctoral theses described aspects of rheumatoid arthritis. He was Chair of the EULAR Standing Committee on Imaging from 2010-2012 and is current Co-Chair of the OMERACT MRI in inflammatory arthritis study group. He is also co-chair of the European Spondyloarthritis Research Collaboration Network (EuroSpA) and member of international spondyloarthritis (ASAS) and psoriasis/psoriatic arthritis (GRAPPA) working groups and of Editorial Boards for several rheumatological journals.
He has supervised/is supervising >35 PhD-studies and has published >500 peer-reviewed articles and >750 international congress abstracts. He has chaired and lectured at imaging workshops at EULAR and ACR congresses for >10 years.
Monday, November 13, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, May 23, 2023); Eli-Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MEDAC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 23, 2023); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Monday, November 13, 2023
4:45 PM – 4:55 PM PT
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, May 23, 2023); Eli-Lilly: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MEDAC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 23, 2023); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)